| Variable | No_CH | CH | P_Value |
|---|---|---|---|
| Female, No. (%) | 135 (53.8) | 85 (52.8) | .924 |
| Male, No. (%) | 116 (46.2) | 76 (47.2) | |
| Age at Sample Collection, Median (IQR) | 62.0 (53.3–69.0) | 68.9 (60.6–75.5) | <.001 |
| Non-Small-Cell Lung Cancer, No. (%) | 76 (30.3) | 58 (36.0) | .238 |
| Breast Cancer, No. (%) | 31 (12.4) | 18 (11.2) | |
| Nonmelanoma Skin Cancer, No. (%) | 18 (7.2) | 11 (6.8) | |
| Melanoma, No. (%) | 19 (7.6) | 9 (5.6) | |
| Note: | |||
| Data from Tao et al. (2025). Bold P-values indicate significance (P < .05). |
8 CH and RT
8.1 Impact of Clonal Hematopoiesis on Solid Tumor Progression Following Radiation Therapy
